First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
for Influenza
1 location in Overland Park
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All·Age: 18 - 59·Accepts healthy volunteers
Code: NCT07169318·Phase 1·Recruiting·Listed Sep 2025